{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T12:15:24Z","timestamp":1783512924345,"version":"3.55.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.apsb.2026.04.011","type":"journal-article","created":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T05:47:50Z","timestamp":1776577670000},"page":"4442-4458","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Acquired pharmacoresistance in temporal lobe epilepsy is driven by Nav1.6-mediated subicular hyperexcitability"],"prefix":"10.1016","volume":"16","author":[{"given":"Yuanzhi","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiongfeng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangshuang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwei","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxiu","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cenglin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2026.04.011_bib1","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1016\/S2468-2667(24)00302-5","article-title":"Global, regional, and national burden of epilepsy, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"10","year":"2025","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.apsb.2026.04.011_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.108026","article-title":"New advances in pharmacoresistant epilepsy towards precise management-from prognosis to treatments","volume":"233","author":"Xu","year":"2022","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.apsb.2026.04.011_bib3","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1111\/epi.14596","article-title":"The epidemiology of drug-resistant epilepsy: a systematic review and meta-analysis","volume":"59","author":"Kalilani","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.apsb.2026.04.011_bib4","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1212\/01.WNL.0000031792.89992.EC","article-title":"How long does it take for partial epilepsy to become intractable?.","volume":"60","author":"Berg","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.apsb.2026.04.011_bib5","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1528-1167.2012.03429.x","article-title":"Onset of intractability and its course over time: the Dutch study of epilepsy in childhood","volume":"53","author":"Geerts","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.apsb.2026.04.011_bib6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.31083\/j.jin2311209","article-title":"Insular epilepsy: functions, diagnostic approaches, and surgical interventions","volume":"23","author":"Ekman","year":"2024","journal-title":"J Integr Neurosci"},{"key":"10.1016\/j.apsb.2026.04.011_bib7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ana.20852","article-title":"How long does it take for epilepsy to become intractable? A prospective investigation","volume":"60","author":"Berg","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.apsb.2026.04.011_bib8","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/ana.25554","article-title":"Subicular pyramidal neurons gate drug resistance in temporal lobe epilepsy","volume":"86","author":"Xu","year":"2019","journal-title":"Ann Neurol"},{"key":"10.1016\/j.apsb.2026.04.011_bib9","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S1474-4422(23)00151-5","article-title":"Drug resistance in epilepsy","volume":"22","author":"Perucca","year":"2023","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.apsb.2026.04.011_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2021.102029","article-title":"Dissecting the role of subiculum in epilepsy: research update and translational potential","volume":"201","author":"Fei","year":"2021","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.apsb.2026.04.011_bib11","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1126\/science.1076510","article-title":"On the origin of interictal activity in human temporal lobe epilepsy in vitro","volume":"298","author":"Cohen","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.apsb.2026.04.011_bib12","doi-asserted-by":"crossref","first-page":"5010","DOI":"10.1038\/s41467-022-32742-x","article-title":"Discrete subicular circuits control generalization of hippocampal seizures","volume":"13","author":"Fei","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.04.011_bib13","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/ana.26173","article-title":"Subicular caspase-1 contributes to pharmacoresistance in temporal lobe epilepsy","volume":"90","author":"Xu","year":"2021","journal-title":"Ann Neurol"},{"key":"10.1016\/j.apsb.2026.04.011_bib14","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.nbd.2012.05.011","article-title":"Wide therapeutic time-window of low-frequency stimulation at the subiculum for temporal lobe epilepsy treatment in rats","volume":"48","author":"Zhong","year":"2012","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.apsb.2026.04.011_bib15","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.0760-24.2024","article-title":"Circuit reorganization of subicular cell-type-specific interneurons in temporal lobe epilepsy","volume":"45","author":"Fei","year":"2025","journal-title":"J Neurosci"},{"key":"10.1016\/j.apsb.2026.04.011_bib16","doi-asserted-by":"crossref","first-page":"7093","DOI":"10.1021\/jm501981g","article-title":"Voltage-gated sodium channels: structure, function, pharmacology, and clinical indications","volume":"58","author":"de Lera Ruiz","year":"2015","journal-title":"J Med Chem"},{"issue":"Suppl 3","key":"10.1016\/j.apsb.2026.04.011_bib17","first-page":"S86","article-title":"SCN8A encephalopathy: mechanisms and models","volume":"60","author":"Meisler","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.apsb.2026.04.011_bib18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1528-1167.2008.01710.x","article-title":"Role of hippocampal sodium channel Nav1.6 in kindling epileptogenesis","volume":"50","author":"Blumenfeld","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.apsb.2026.04.011_bib19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.nbd.2017.08.018","article-title":"Pro-excitatory alterations in sodium channel activity facilitate subiculum neuron hyperexcitability in temporal lobe epilepsy","volume":"108","author":"Barker","year":"2017","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.apsb.2026.04.011_bib20","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/s12264-020-00482-x","article-title":"Low-frequency stimulation at the subiculum is anti-convulsant and anti-drug-resistant in a mouse model of lamotrigine-resistant temporal lobe epilepsy","volume":"36","author":"Ruan","year":"2020","journal-title":"Neurosci Bull"},{"key":"10.1016\/j.apsb.2026.04.011_bib21","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/s41467-020-14648-8","article-title":"A disinhibitory nigra-parafascicular pathway amplifies seizure in temporal lobe epilepsy","volume":"11","author":"Chen","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.04.011_bib22","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.biopsych.2019.11.014","article-title":"Direct septum-hippocampus cholinergic circuit attenuates seizure through driving somatostatin inhibition","volume":"87","author":"Wang","year":"2020","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.apsb.2026.04.011_bib23","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","article-title":"Modification of seizure activity by electrical stimulation. II. Motor seizure","volume":"32","author":"Racine","year":"1972","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1016\/j.apsb.2026.04.011_bib24","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1111\/j.1499-1654.2000.001514.x","article-title":"Lamotrigine treatment during amygdala-kindled seizure development fails to inhibit seizures and diminishes subsequent anticonvulsant efficacy","volume":"41","author":"Postma","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.apsb.2026.04.011_bib25","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/epi4.12354","article-title":"Evaluation of antiseizure drug efficacy and tolerability in the rat lamotrigine-resistant amygdala kindling model","volume":"4","author":"Metcalf","year":"2019","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.apsb.2026.04.011_bib26","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1038\/s41401-025-01594-8","article-title":"Neuroinflammation leads to pharmacoresistance in temporal lobe epilepsy via promoting spermine degradation","volume":"46","author":"Yan","year":"2025","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.apsb.2026.04.011_bib27","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1111\/j.1476-5381.2009.00301.x","article-title":"Actions of veratridine on tetrodotoxin-sensitive voltage-gated Na currents, Na1.6, in murine vas deferens myocytes","volume":"157","author":"Zhu","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.apsb.2026.04.011_bib28","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/epi.12234","article-title":"Rapid loss of efficacy to the antiseizure drugs lamotrigine and carbamazepine: a novel experimental model of pharmacoresistant epilepsy","volume":"54","author":"Srivastava","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.apsb.2026.04.011_bib29","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41467-017-00368-z","article-title":"CDYL suppresses epileptogenesis in mice through repression of axonal Nav1.6 sodium channel expression","volume":"8","author":"Liu","year":"2017","journal-title":"Nat Commun"},{"issue":"Suppl 1","key":"10.1016\/j.apsb.2026.04.011_bib30","first-page":"S34","article-title":"Transporter hypothesis in pharmacoresistant epilepsies. Is it at the central or peripheral level?.","volume":"7","author":"Czornyj","year":"2022","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.apsb.2026.04.011_bib31","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1111\/j.1528-1167.2012.03631.x","article-title":"Sodium channels and the neurobiology of epilepsy","volume":"53","author":"Oliva","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.apsb.2026.04.011_bib32","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1152\/jn.00383.2013","article-title":"Evidence for a role of Nav1.6 in facilitating increases in neuronal hyperexcitability during epileptogenesis","volume":"110","author":"Hargus","year":"2013","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.apsb.2026.04.011_bib33","doi-asserted-by":"crossref","DOI":"10.1172\/JCI166271","article-title":"Exosomal TNF-alpha mediates voltage-gated Na+ channel 1.6 overexpression and contributes to brain tumor-induced neuronal hyperexcitability","volume":"134","author":"Sanchez Trivino","year":"2024","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2026.04.011_bib34","doi-asserted-by":"crossref","first-page":"8489","DOI":"10.1523\/JNEUROSCI.1534-10.2010","article-title":"Efficacy loss of the anticonvulsant carbamazepine in mice lacking sodium channel beta subunits via paradoxical effects on persistent sodium currents","volume":"30","author":"Uebachs","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.apsb.2026.04.011_bib35","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1111\/j.1528-1167.2012.03675.x","article-title":"Loss of beta1 accessory Na+ channel subunits causes failure of carbamazepine, but not of lacosamide, in blocking high-frequency firing via differential effects on persistent Na+ currents","volume":"53","author":"Uebachs","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.apsb.2026.04.011_bib36","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/s12883-021-02395-2","article-title":"Response to sodium channel blocking antiseizure medications and coding polymorphisms of sodium channel genes in taiwanese epilepsy patients","volume":"21","author":"Lin","year":"2021","journal-title":"BMC Neurol"},{"key":"10.1016\/j.apsb.2026.04.011_bib37","doi-asserted-by":"crossref","first-page":"9270","DOI":"10.1073\/pnas.93.17.9270","article-title":"Common molecular determinants of local anesthetic, antiarrhythmic, and anticonvulsant block of voltage-gated Na+ channels","volume":"93","author":"Ragsdale","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2026.04.011_bib38","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1126\/science.8085162","article-title":"Molecular determinants of state-dependent block of Na+ channels by local anesthetics","volume":"265","author":"Ragsdale","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.apsb.2026.04.011_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107790","article-title":"Pharmacoresistance\u2014Epidemiology, mechanisms, and impact on epilepsy treatment","volume":"168","author":"Janmohamed","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.apsb.2026.04.011_bib40","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.87559","article-title":"Coupling of slack and Na(V)1.6 sensitizes slack to quinidine blockade and guides anti-seizure strategy development","volume":"12","author":"Yuan","year":"2024","journal-title":"eLife"},{"key":"10.1016\/j.apsb.2026.04.011_bib41","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1515\/revneuro-2020-0091","article-title":"The subiculum and its role in focal epileptic disorders","volume":"32","author":"Levesque","year":"2021","journal-title":"Rev Neurosci"},{"key":"10.1016\/j.apsb.2026.04.011_bib42","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1535-7511.2005.00049.x","article-title":"The role of the subiculum in epilepsy and epileptogenesis","volume":"5","author":"Stafstrom","year":"2005","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.apsb.2026.04.011_bib43","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1113\/jphysiol.2005.088708","article-title":"Rat subicular networks gate hippocampal output activity in an in vitro model of limbic seizures","volume":"566","author":"Benini","year":"2005","journal-title":"J Physiol"},{"key":"10.1016\/j.apsb.2026.04.011_bib44","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neuron.2017.06.004","article-title":"Depolarized GABAergic signaling in subicular microcircuits mediates generalized seizure in temporal lobe epilepsy","volume":"95","author":"Wang","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.apsb.2026.04.011_bib45","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/nn.2359","article-title":"Distinct contributions of Na(v)1.6 and Na(v)1.2 in action potential initiation and backpropagation","volume":"12","author":"Hu","year":"2009","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.apsb.2026.04.011_bib46","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12974-019-1421-8","article-title":"TNF-alpha\/STAT3 pathway epigenetically upregulates Nav1.6 expression in DRG and contributes to neuropathic pain induced by L5-VRT","volume":"16","author":"Ding","year":"2019","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.apsb.2026.04.011_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2024.105699","article-title":"Current advances in rodent drug-resistant temporal lobe epilepsy models: hints from laboratory studies","volume":"174","author":"Zhang","year":"2024","journal-title":"Neurochem Int"},{"key":"10.1016\/j.apsb.2026.04.011_bib48","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1124\/pr.120.019539","article-title":"Drug resistance in epilepsy: clinical impact, potential mechanisms, and new innovative treatment options","volume":"72","author":"Loscher","year":"2020","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.apsb.2026.04.011_bib49","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s40263-021-00827-8","article-title":"The pharmacology and clinical efficacy of antiseizure medications: from bromide salts to cenobamate and beyond","volume":"35","author":"Loscher","year":"2021","journal-title":"CNS Drugs"},{"key":"10.1016\/j.apsb.2026.04.011_bib50","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1016\/j.apsb.2025.03.024","article-title":"Modulating inflammatory prostaglandin E2 signaling to mitigate neurobehavioral comorbidities associated with seizure disorders","volume":"15","author":"Jiang","year":"2025","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2026.04.011_bib51","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S2352-4642(18)30099-3","article-title":"Adjunctive everolimus for children and adolescents with treatment-refractory seizures associated with Tuberous sclerosis complex: post-hoc analysis of the phase 3 EXIST-3 trial","volume":"2","author":"Curatolo","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.apsb.2026.04.011_bib52","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s40263-021-00807-y","article-title":"Highly purified cannabidiol for epilepsy treatment: a systematic review of epileptic conditions beyond Dravet syndrome and lennox-gastaut syndrome","volume":"35","author":"Lattanzi","year":"2021","journal-title":"CNS Drugs"},{"key":"10.1016\/j.apsb.2026.04.011_bib53","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1474-4422(10)70059-4","article-title":"Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders","volume":"9","author":"Mantegazza","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.apsb.2026.04.011_bib54","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1113\/jphysiol.2011.224204","article-title":"Voltage-gated sodium channels at 60: structure, function and pathophysiology","volume":"590","author":"Catterall","year":"2012","journal-title":"J Physiol"},{"key":"10.1016\/j.apsb.2026.04.011_bib55","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.72468","article-title":"NBI-921352, a first-in-class, NaV1.6 selective, sodium channel inhibitor that prevents seizures in Scn8a gain-of-function mice, and wild-type mice and rats","volume":"11","author":"Johnson","year":"2022","journal-title":"eLife"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526002510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526002510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T11:27:17Z","timestamp":1783510037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383526002510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":55,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2211383526002510"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2026.04.011","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acquired pharmacoresistance in temporal lobe epilepsy is driven by Nav1.6-mediated subicular hyperexcitability","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2026.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}